Sangeeta Tanna has a PhD in Pharmaceutics and is a Reader in Pharmaceutical Bioanalysis. Her expertise and research interests are the pharmaceutical bioanalysis and drug delivery fields. Her early research focused on developing instrumental methods for measuring the glucose-dependent delivery of insulin from a “smart gel. This led to the development of microanalytical methodologies for the determination of therapeutic drugs from dried blood spots based on LC-MS, LC-MS/MS, and LC-HRMS studies. Applications of this work to patient healthcare include improved medications for newborn babies and to assess adherence to cardiovascular drug therapy for adult patients. She has a track record of published papers, invited international conference presentations, grants, and awards for this research.
